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From the Editor
Farm animals are important biomedical models
Debora L. Hamernik
Office of Research and Economic Development, University of Nebraska-Lincoln, Lincoln, NE 68588-0433 
This issue of  Animal Frontiers, “Farm animals are im-
portant biomedical models,” describes several examples in 
which cattle, sheep, pigs, or chickens provide an excellent 
physiological model for studies related to human health or 
disease (Figure 1). While previous reports have discussed the 
use of  domestic animals as dual-purpose models that benefit 
agricultural and biomedical research (Ireland et al., 2008), 
this issue of  Animal Frontiers provides additional and novel 
examples of  the value of  farm animals for biomedical re-
search. Because farm animals are larger in size than labora-
tory species, scientists are able to collect larger volumes and 
more frequent samples of  blood without significant changes 
in blood chemistry or substantive changes in blood volume 
as well as larger or more frequent tissue biopsies, thereby al-
lowing the study of  changes in hormones, metabolites, im-
mune factors, or cellular components in the same animal over 
time. Many of  these studies revealed that the physiology of 
humans is more closely related to the physiology of  farm ani-
mals than to rodents. Finally, the human genome sequence 
is more similar to the genome sequences of  cattle and pigs 
compared with rodents (Humphray et al., 2007; Tellam et al., 
2009); thus, cattle and pigs may be better models for many 
human genetic diseases.
The article by Proudfoot et al. (2019) discusses use of gene 
editing in pigs and the potential to use this technology in 
chickens to generate disease-resistant animals. Gene editing 
allows modification of a single gene or single nucleotide 
polymorphism without the addition of foreign DNA to the 
animal’s genome. Gene-edited pigs that are resistant to infec-
tion by important viral diseases, such as porcine reproductive 
and respiratory syndrome virus or transmissible gastroenteritis 
virus, have recently been produced. The avian egg has very dif-
ferent physiology compared with mammalian eggs; thus, gene 
editing in poultry has not yet been reported. However, use of 
chicken stem cells may provide a new method for successful 
gene editing in poultry. While the production of gene-edited 
farm animals holds tremendous potential for enhancing disease 
resistance, use of these animals is also likely to enhance our 
understanding of transmission of zoonotic diseases between 
animals and humans as well as our understanding of disease 
resistance in humans. As with any new technology, consumer 
acceptance and use of a science-based regulatory framework 
will determine whether or not the technology will be available 
to treat diseases in humans.
Wolf et al. (2019) describe production of genetically modified 
pigs as a source of cells, tissues, or organs for xenotransplant-
ation. Pigs may be an important donor for human transplant 
tissues because many pig organs and tissues are similar to 
humans and pig cells can be genetically engineered to over-
come issues associated with the risk of transmission of zoo-
notic pathogens or rejection of transplant tissues. To prevent 
hyperacute rejection of pig tissues in non-human primates, gene 
targeting or gene editing was used to knockout antigens (e.g., 
galactose-α1,3-galactose [αGal] or α-1,3-galactosyltransferase 
[GGTA1]) on pig cells that are not found on cells in humans 
and Old World monkeys and transgenic technology was used 
to express one or more human complement-regulatory pro-
teins in pig cells. This technology holds significant promise for 
Figure 1. Schematic depicting the use of cattle, pigs, sheep, and chickens as 
models for biomedical research.
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thousands of people waiting for transplants of pancreatic is-
lets, neuronal cells, corneas, hearts, or kidneys.
Studies with farm animals in the areas of muscle develop-
ment and metabolism are informative for animal production as 
well as human health as discussed by Zhao et al. (2019). The 
composition of muscle fibers affects growth efficiency and meat 
quality in farm animals and is associated with metabolic syn-
drome in humans. In skeletal muscle and brown adipose tissue, 
thermogenesis increases energy expenditure and heat produc-
tion, which reduces feed efficiency in farm animals (an undesir-
able situation) and prevents obesity and metabolic diseases in 
humans (desirable conditions). While dysregulation of satellite 
cells and fibro/adipogenic progenitor cells leads to the favor-
able characteristic of increased intramuscular fat (or marbling) 
in cattle, this situation leads to muscle atrophy, fatty infiltra-
tion, and fibrosis in humans. Thus, understanding the cellular 
and molecular mechanisms that regulate skeletal muscle de-
velopment and metabolism are essential for improving human 
health.
Abedal-Majed and Cupp (2019) describe livestock models 
to study infertility in humans. In most mammals, anovulation is 
a major cause of infertility. Pigs, sheep, and cattle have advan-
tages to rodents as biomedical models and many studies con-
ducted with these species have direct relevance to reproductive 
disorders in women. For example, polycystic ovarian syndrome 
(PCOS) is a multifactorial disorder that affects up to 20% of 
women of reproductive age (Di Pietro et al., 2015). Recently, a 
subpopulation of beef cows with excess intrafollicular andro-
stenedione (A4; High A4 beef cows) and molecular pheno-
types in ovarian theca cells was found to represent a naturally 
occurring, androgen excess animal model that is similar to 
women diagnosed with PCOS and subfertility. Thus, High A4 
beef cows could be used to identify new cellular and molecular 
mechanisms regulating PCOS and/or develop potential treat-
ments for PCOS in the future.
Intrauterine growth restriction (IUGR) is associated with in-
creased mortality rates early in life and various metabolic dis-
orders that may lead to reduced quality and duration of life in 
affected individuals in a variety of species. Beede et al. (2019) 
describe the use of pregnant sheep to study IUGR to advance 
our understanding of the mechanisms associated with adaptive 
fetal programming and metabolic dysfunction. Results indicate 
that adrenergic and inflammatory pathways are involved in 
regulation of skeletal muscle growth and glucose metabolism. 
Continued use of the pregnant sheep model may lead to pre-
natal interventions or postnatal treatments to improve out-
comes in IUGR-born offspring.
Pregnant sheep and catheterized fetal sheep have been 
widely used to study normal and abnormal fetal development, 
as well as in utero treatment options for congenital birth de-
fects under a variety of experimental conditions that could not 
be studied in human fetuses. Varcoe et al. (2019) summarize the 
most commonly used analgesics in fetal sheep studies and dis-
cuss the potential impacts of each drug on maternal pain and 
fetal well-being. Unlike ewes, it is not possible to directly assess 
effects of analgesia on fetal lambs. The authors also discuss 
various factors to consider when providing post-surgical an-
esthesia, such as route of administration, transport across the 
placenta, and metabolism of the drug by the placenta.
Ella et al. (2019) describe the use of various brain imaging 
technologies in farm animals, such as x-rays, magnetic reson-
ance imaging (MRI), and computerized tomography scans. 
While these technologies have been used widely for brain 
imaging in human clinical studies, use of these technologies for 
brain imaging in farm animals has only recently been devel-
oped. A sheep model of Batten disease that shares many neuro-
pathological features with humans has recently been described. 
The combined use of MRI imaging to monitor the brain in 
vivo and gene therapy with three different viral vectors in the 
ovine model of Batten disease provides an exciting opportunity 
for future clinical and translational studies with humans.
Food allergies, especially soy food allergies, are relatively 
common in humans and are a growing concern in companion 
animals. Radcliffe et al. (2019) discuss a subset of pigs that nat-
urally develop allergies to soy. This pig model of soy protein-
induced food allergenicity will be an important system for 
gaining new information regarding the genetic, genomic, bio-
chemical, and physiological mechanisms associated with food 
allergenicity as well as development of potential intervention 
strategies that may be useful in humans.
Although zebrafish are not considered a farm animal, 
the importance of zebrafish in biomedical research cannot 
be discounted. Teame et al. (2019) identify several unique 
physiological characteristics of zebrafish, including external 
fertilization and development of nearly transparent embryos 
outside the uterus, that make zebrafish an interesting bio-
medical model. The authors also describe a standard diet for 
zebrafish larvae and adults, which should facilitate generation 
of consistent results in metabolic studies with zebrafish across 
laboratories throughout the world. Zebrafish may also be used 
to develop new therapies to prevent or treat important diseases 
in humans.
In conclusion, this issue of Animal Frontiers describes sev-
eral novel uses of farm animals and zebrafish to gain a better 
understanding of the mechanisms underlying human diseases. 
The ability to collect frequent blood samples and(or) multiple 
tissue biopsies from farm animals; the similar physiology be-
tween farm animals and humans; the similar genome sequence 
between cattle, pigs, and humans; and the ability to genetically 
modify farm animals by gene targeting, gene editing, and(or) 
transgenesis are excellent advantages to the use of farm ani-
mals compared with traditional laboratory species when 
studying human diseases. Development of new technologies 
will likely allow further use of farm animals as additional bio-
medical models in the future.
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